These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17713437)

  • 1. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
    Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
    Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotomous effects of rosiglitazone in transplantation-induced systemic vasodilator dysfunction in rats.
    Onuta G; Hillebrands JL; Rienstra H; Boer MW; Klatter FA; Navis G; Rozing J; Roks AJ
    Transplantation; 2008 Feb; 85(4):582-8. PubMed ID: 18347538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
    Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype.
    Bojakowski K; Religa P; Bojakowska M; Hedin U; Gaciong Z; Thyberg J
    Transplantation; 2000 Jul; 70(1):65-72. PubMed ID: 10919577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.
    Alkhatib B; Freguin-Bouilland C; Litzler PY; Jacquot S; Lallemand F; Henry JP; Thuillez C; Plissonnier D
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):791-7. PubMed ID: 17320586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
    Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
    Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
    Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
    Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense ERK1/2 oligodeoxynucleotide gene therapy attenuates graft arteriosclerosis of aortic transplant in a rat model.
    Dong C; Gong N; Chen Z; Chen X; Xu Q; Guo H; Zeng Z; Ming C; Chen ZK
    Transplant Proc; 2006 Dec; 38(10):3304-6. PubMed ID: 17175255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordyceps sinensis extracts attenuate aortic transplant arteriosclerosis in rats.
    Zhang Y; Yang M; Gong S; Yang Y; Chen B; Cai Y; Zheng S; Yang Y; Xia P
    J Surg Res; 2012 Jun; 175(1):123-30. PubMed ID: 21492877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis.
    Sakihama H; Masunaga T; Yamashita K; Hashimoto T; Inobe M; Todo S; Uede T
    Circulation; 2004 Nov; 110(18):2924-30. PubMed ID: 15505104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.
    Warnecke G; Bushell A; Nadig SN; Wood KJ
    Transplantation; 2007 Jun; 83(11):1459-65. PubMed ID: 17565319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.
    Murthy SN; Obregon DF; Chattergoon NN; Fonseca NA; Mondal D; Dunne JB; Diez JG; Jeter JR; Kadowitz PJ; Agrawal KC; McNamara DB; Fonseca VA
    Metabolism; 2005 May; 54(5):645-52. PubMed ID: 15877295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
    Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
    Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
    Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
    Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDF-1 plays a key role in the repairing and remodeling process on rat allo-orthotopic abdominal aorta grafts.
    Gao C; Li Y
    Transplant Proc; 2007; 39(1):268-72. PubMed ID: 17275519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.